Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.41 |
| ▸ | MMP2 | P08253 | 2/20 | 0.41 |
| ▸ | MMP9 | P14780 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.38 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.37 |
| ▸ | GGH | Q92820 | 1/20 | 0.37 |
| ▸ | BMP1 | P13497 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1221387 | 1.00 | KMT2A (0.45) | KMT2AALOX15BLMPMP22FOLH1 | |
| D-Glutamate SCHEMBL8219044 | 0.87 | ALOX15 (0.56) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL1226603 | 0.86 | KMT2A (0.47) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL1226605 | 0.86 | KMT2A (0.47) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL15387335 | 0.85 | KMT2A (0.50) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL27546760 | 0.85 | KMT2A (0.50) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL24165071 | 0.84 | KMT2A (0.48) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL4655466 | 0.84 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGGH | |
| SCHEMBL7762307 | 0.83 | KMT2A (0.44) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL2248015 | 0.83 | KMT2A (0.44) | KMT2AALOX15BLMPMP22FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109293926-B | Protease responsive linear-dendritic block copolymer and preparation method and application thereof | 云南师范大学 | 2021-04-23 | — | — | CN | claimed |
| CN-111936150-A | Anticancer microRNA and lipid preparation thereof | 因特尔纳技术有限公司 | 2020-11-13 | — | — | CN | claimed |
| US-20100145018-A1 | Lipid-Polymer-Conjugates | ASTELLAS PHARMA EUROPE BV (NL) | 2010-06-10 | — | — | US | claimed |
| US-20050180917-A1 | Delivery of neutron capture elements for neutron capture therapy | PSIMEI PHARMACEUTICALS PLC (GB) | 2005-08-18 | — | — | US | claimed |
| EP-1471939-A1 | DELIVERY OF NEUTRON CAPTURE ELEMENTS FOR NEUTRON CAPTURE THERAPY | Psimei Pharmaceuticals Plc (GB) | 2004-11-03 | — | — | EP | claimed |
| WO-2003055520-A1 | DELIVERY OF NEUTRON CAPTURE ELEMENTS FOR NEUTRON CAPTURE THERAPY | PSIMEI PHARMACEUTICALS PLC (GB) | 2003-07-10 | — | — | WO | claimed |
| EP-0213996-A1 | Ramified polymers based on lipopeptides forming thermotropic and lyotropic liquid crystals, their use and corresponding monomers | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1987-03-11 | — | — | EP | claimed |
| US-20260125614-A1 | IONIZABLE CATIONIC LIPIDS | AKAGERA MEDICINES, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| US-12606773-B2 | Ionizable cationic lipids | AKAGERA MEDICINES, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-20260083674-A1 | OXAZOLIDINONE LIPOSOME COMPOSITIONS | AKAGERA MEDICINES, INC. (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260077038-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | AKAGERA MEDICINES, INC. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260069684-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | AKAGERA MEDICINES, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260055335-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS | AKAGERA MEDICINES, INC. (US) | 2026-02-26 | — | — | US | disclosed |
| US-5172132-A | Digital image forming device and method for forming an image from a plurality of dots | KONICA CORPORATION (JP) | 1992-12-15 | — | — | US | disclosed |
| EP-0465074-A1 | Image forming apparatus | KONICA CORPORATION (JP) | 1992-01-08 | — | — | EP | disclosed |
| EP-0464349-A2 | Image forming apparatus and method | KONICA CORPORATION (JP) | 1992-01-08 | — | — | EP | disclosed |
| WO-1991015242-A1 | CONJUGATE COMPOUNDS OF POLYMERS WITH OTHER ORGANIC MOLECULAR ENTITIES | SCHACHT ETIENNE HONORE (BE) | 1991-10-17 | — | — | WO | disclosed |
| EP-0451770-A2 | Image forming apparatus | KONICA CORPORATION (JP) | 1991-10-16 | — | — | EP | disclosed |
| EP-0164569-B1 | A MEDICINE-RELEASING AGENT | KOKEN CO. LTD. (JP) | 1990-10-31 | — | — | EP | disclosed |
| EP-0213996-B1 | RAMIFIED POLYMERS BASED ON LIPOPEPTIDES FORMING THERMOTROPIC AND LYOTROPIC LIQUID CRYSTALS, THEIR USE AND CORRESPONDING MONOMERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1989-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069684-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | PHOSPHO1, PLTP, SGMS1 | KMT2A 2511/4885ALOX15 736/4885BLM 4002/4885 |
| US-20100145018-A1 | Lipid-Polymer-Conjugates | PARG, GLUL, PHOSPHO1 | KMT2A 212/4885ALOX15 1425/4885BLM 1503/4885 |
| US-20260077038-A1 | LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF | PHOSPHO1, LNPK, SGMS2 | KMT2A 609/4885ALOX15 2875/4885BLM 4154/4885 |
| US-20260125614-A1 | IONIZABLE CATIONIC LIPIDS | CPT2, NPC1L1, PNPLA2 | KMT2A 487/4885ALOX15 237/4885BLM 1936/4885 |
| US-12606773-B2 | Ionizable cationic lipids | NPC1L1, MCOLN1, SLC22A4 | KMT2A 966/4885ALOX15 1321/4885BLM 343/4885 |
| US-20260055335-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS | CD4, LDLR, CD2BP2 | KMT2A 1769/4885ALOX15 259/4885BLM 4382/4885 |
| US-20260083674-A1 | OXAZOLIDINONE LIPOSOME COMPOSITIONS | TBCD, SLK, PLA2G2C | KMT2A 1771/4885ALOX15 3482/4885BLM 3845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.